U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H27N5O4
Molecular Weight 389.4488
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-(3-((4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)AMINO)PROPYL)TETRAHYDRO-N-METHYL-2-FURANCARBOXAMIDE

SMILES

COC1=CC2=NC(NCCCN(C)C(=O)C3CCCO3)=NC(N)=C2C=C1OC

InChI

InChIKey=HFYGLILDBTWNBI-UHFFFAOYSA-N
InChI=1S/C19H27N5O4/c1-24(18(25)14-6-4-9-28-14)8-5-7-21-19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H3,20,21,22,23)

HIDE SMILES / InChI

Approval Year

Unknown
139594
Name Type Language
N-(3-((4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)AMINO)PROPYL)TETRAHYDRO-N-METHYL-2-FURANCARBOXAMIDE
Systematic Name English
2-FURANCARBOXAMIDE, N-(3-((4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)AMINO)PROPYL)TETRAHYDRO-N-METHYL-
Systematic Name English
ALFUZOSIN HYDROCHLORIDE IMPURITY C [EP IMPURITY]
Common Name English
(2RS)-N-(3-((4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)AMINO)PROPYL)-N-METHYLOXOLAN-2-CARBOXAMIDE
Systematic Name English
Code System Code Type Description
PUBCHEM
13544708
Created by admin on Sat Dec 16 05:50:18 GMT 2023 , Edited by admin on Sat Dec 16 05:50:18 GMT 2023
PRIMARY
FDA UNII
4LL05323WJ
Created by admin on Sat Dec 16 05:50:18 GMT 2023 , Edited by admin on Sat Dec 16 05:50:18 GMT 2023
PRIMARY
CAS
98902-34-2
Created by admin on Sat Dec 16 05:50:18 GMT 2023 , Edited by admin on Sat Dec 16 05:50:18 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966